Here, we report that the modification of liposome surfaces with AG73 peptides enhances delivery of the lipophilic anticancer drug, edelfosine, to tumor cells ov
In the development of new drugs as well as new formulations of existing products(including generic products),it is of great interest to be able to predict to wh